Girls' Energy and Fat Intake
- Mean energy intake = 1526kcal (84.8% of recommended dietary allowances)
- 45% of girls consumed diets with less than 30% of energy from fat (LF) (N=84) vs. HF (at least 30% kcal) (N=108).
Demographic Information by Fat Intake Level
No significant differences between LF and HF groups, respectively for:
- Education: Average 15 years for both
- Household income: 73.5% and 70.4% had incomes more than $35,000
- Percentage of working mothers: 62% and 64%.
Girls' Food Group Intake by Fat Intake Level
- Compared to girls on LF diets, girls on HF diets consumed significantly more servings of fats, sweets and meat; girls in both groups consumed less than recommended two servings per day (P < 0.05)
- Servings of grains: NS between HF and LF groups
- Servings of fruit: LF=1.8 vs. HF=1.3 (P<0.05)
- Servings of vegetables: NS between HF (1.5) and LF (1.7); only ~ 8% of girls consumed recommended number of servings
- Dairy: NS between HF and LF; girls in both groups consumed more servings of dairy foods than the recommended two servings per day.
Healthy Eating Index (HEI)
- Total HEI scores of both groups corresponded to "a diet that needs improvement," but scores for both groups were higher than those reported for US girls of the same age
- LF had significantly higher HEI scores than HF, even when excluding fat subscales
Girls' Energy and Nutrient Intake by Fat Intake Level
- Energy intake: NS between HF and LF (trend for higher in HF)
- Carbohydrate intake: Higher for LF (233±1.6g) than HF (205±1.4g) (P<0.05)
- Protein intake: NS
- Fiber: LF (11.8±0.3g) greater than HF (10.1±0.3g) (P<0.05)
- Micronutrients: LF had significantly (P<0.05) higher intakes of vitamins A, C, thiamin, B6, folate, and niacin and of iron and magnesium.
Girls' Weight Status by Fat Intake Level
No significant differences in BMI between groups at five or seven years old.
Mothers' Feeding Practicies by Girls' Fat Intake Level
- Maternal restriction and pressure to eat scores were higher for mothers of girls in HF than LF group
- Relationship between mothers' feeding practices and girls' macronutrient intake, controlling for girls' BMI:
- Maternal restriction (r=0.17; P=0.01) and pressure to eat (r=0.16; P=0.02) were positively related to girls' percentage total energy from fat
- Carbohydrate, protein and energy intake were not related to mothers' feeding practices.
Mothers' Energy and Nutrient Intakes by Girls' Fat Intake Level
- Mothers of girls in the HF group consumed more fat (75±0.13g) and less carbohydrates (216±3.5g) than mothers of girls in the LF group (70±1.5g fat; 227±4.0g CHO)
- Energy and protein intakes were NS
- LF group mothers had greater fiber intakes (16.3±0.6g) than HF group mothers (14.4±0.5g)
- Mothers' and daughters' fat intake (percent of kcal): r=0.31; P=0.0001
- Mothers' and daughters' energy intake: r=0.15; P=0.03
- Mothers' and daughters' carbohydrate intake: r =0.21; P=0.003
- Mothers of girls in the LF group had higher intakes of vitamins A, C, riboflavin, folate and magnesium (P<0.05)
- Calcium intakes were higher in mothers of girls consuming LF diets (P<0.05)
- Pattern of differences in nutrient intakes for mothers of girls in HF and LF groups were similar to those noted for their daughters.
Weight Status by Fat Intake Level
- Change in BMI from five to seven years of age was significantly greater for girls on HF diets than LF and the same result was obtained when controlling for BMI at age five years
- Change in sum of skinfold thickness (sum of triceps and subscapular) was also significantly higher in HF group than in the LF group. Girls who consumed relatively more energy from fat at age five years gained more subcutaneous fat from ages five to seven years.
- Fat intake (% of energy intake) was positively correlated with change in BMI from ages five to seven years (r=0.14; P<0.05), whereas carbohydrate intake was negatively related to change in BMI from ages five to seven years (r=-0.19; P<0.01).
|
Research Design and Implementation Criteria Checklist: Primary Research
|
|
Relevance Questions
|
| |
1.
|
Would implementing the studied intervention or procedure (if found successful) result in improved outcomes for the patients/clients/population group? (Not Applicable for some epidemiological studies) |
Yes
|
| |
2.
|
Did the authors study an outcome (dependent variable) or topic that the patients/clients/population group would care about? |
Yes
|
| |
3.
|
Is the focus of the intervention or procedure (independent variable) or topic of study a common issue of concern to nutrition or dietetics practice? |
Yes
|
| |
4.
|
Is the intervention or procedure feasible? (NA for some epidemiological studies) |
N/A
|
| |
|
Validity Questions
|
| 1. |
Was the research question clearly stated? |
Yes
|
| |
1.1.
|
Was (were) the specific intervention(s) or procedure(s) [independent variable(s)] identified? |
Yes
|
| |
1.2.
|
Was (were) the outcome(s) [dependent variable(s)] clearly indicated? |
Yes
|
| |
1.3.
|
Were the target population and setting specified? |
Yes
|
| 2. |
Was the selection of study subjects/patients free from bias? |
Yes
|
| |
2.1.
|
Were inclusion/exclusion criteria specified (e.g., risk, point in disease progression, diagnostic or prognosis criteria), and with sufficient detail and without omitting criteria critical to the study? |
Yes
|
| |
2.2.
|
Were criteria applied equally to all study groups? |
Yes
|
| |
2.3.
|
Were health, demographics, and other characteristics of subjects described? |
Yes
|
| |
2.4.
|
Were the subjects/patients a representative sample of the relevant population? |
No
|
| 3. |
Were study groups comparable? |
Yes
|
| |
3.1.
|
Was the method of assigning subjects/patients to groups described and unbiased? (Method of randomization identified if RCT) |
Yes
|
| |
3.2.
|
Were distribution of disease status, prognostic factors, and other factors (e.g., demographics) similar across study groups at baseline? |
Yes
|
| |
3.3.
|
Were concurrent controls used? (Concurrent preferred over historical controls.) |
Yes
|
| |
3.4.
|
If cohort study or cross-sectional study, were groups comparable on important confounding factors and/or were preexisting differences accounted for by using appropriate adjustments in statistical analysis? |
Yes
|
| |
3.5.
|
If case control or cross-sectional study, were potential confounding factors comparable for cases and controls? (If case series or trial with subjects serving as own control, this criterion is not applicable. Criterion may not be applicable in some cross-sectional studies.) |
Yes
|
| |
3.6.
|
If diagnostic test, was there an independent blind comparison with an appropriate reference standard (e.g., "gold standard")? |
N/A
|
| 4. |
Was method of handling withdrawals described? |
Yes
|
| |
4.1.
|
Were follow-up methods described and the same for all groups? |
Yes
|
| |
4.2.
|
Was the number, characteristics of withdrawals (i.e., dropouts, lost to follow up, attrition rate) and/or response rate (cross-sectional studies) described for each group? (Follow up goal for a strong study is 80%.) |
Yes
|
| |
4.3.
|
Were all enrolled subjects/patients (in the original sample) accounted for? |
Yes
|
| |
4.4.
|
Were reasons for withdrawals similar across groups? |
N/A
|
| |
4.5.
|
If diagnostic test, was decision to perform reference test not dependent on results of test under study? |
N/A
|
| 5. |
Was blinding used to prevent introduction of bias? |
Yes
|
| |
5.1.
|
In intervention study, were subjects, clinicians/practitioners, and investigators blinded to treatment group, as appropriate? |
N/A
|
| |
5.2.
|
Were data collectors blinded for outcomes assessment? (If outcome is measured using an objective test, such as a lab value, this criterion is assumed to be met.) |
Yes
|
| |
5.3.
|
In cohort study or cross-sectional study, were measurements of outcomes and risk factors blinded? |
Yes
|
| |
5.4.
|
In case control study, was case definition explicit and case ascertainment not influenced by exposure status? |
N/A
|
| |
5.5.
|
In diagnostic study, were test results blinded to patient history and other test results? |
N/A
|
| 6. |
Were intervention/therapeutic regimens/exposure factor or procedure and any comparison(s) described in detail? Were interveningfactors described? |
Yes
|
| |
6.1.
|
In RCT or other intervention trial, were protocols described for all regimens studied? |
N/A
|
| |
6.2.
|
In observational study, were interventions, study settings, and clinicians/provider described? |
Yes
|
| |
6.3.
|
Was the intensity and duration of the intervention or exposure factor sufficient to produce a meaningful effect? |
Yes
|
| |
6.4.
|
Was the amount of exposure and, if relevant, subject/patient compliance measured? |
N/A
|
| |
6.5.
|
Were co-interventions (e.g., ancillary treatments, other therapies) described? |
N/A
|
| |
6.6.
|
Were extra or unplanned treatments described? |
N/A
|
| |
6.7.
|
Was the information for 6.4, 6.5, and 6.6 assessed the same way for all groups? |
Yes
|
| |
6.8.
|
In diagnostic study, were details of test administration and replication sufficient? |
N/A
|
| 7. |
Were outcomes clearly defined and the measurements valid and reliable? |
Yes
|
| |
7.1.
|
Were primary and secondary endpoints described and relevant to the question? |
Yes
|
| |
7.2.
|
Were nutrition measures appropriate to question and outcomes of concern? |
Yes
|
| |
7.3.
|
Was the period of follow-up long enough for important outcome(s) to occur? |
Yes
|
| |
7.4.
|
Were the observations and measurements based on standard, valid, and reliable data collection instruments/tests/procedures? |
Yes
|
| |
7.5.
|
Was the measurement of effect at an appropriate level of precision? |
Yes
|
| |
7.6.
|
Were other factors accounted for (measured) that could affect outcomes? |
Yes
|
| |
7.7.
|
Were the measurements conducted consistently across groups? |
Yes
|
| 8. |
Was the statistical analysis appropriate for the study design and type of outcome indicators? |
Yes
|
| |
8.1.
|
Were statistical analyses adequately described and the results reported appropriately? |
Yes
|
| |
8.2.
|
Were correct statistical tests used and assumptions of test not violated? |
Yes
|
| |
8.3.
|
Were statistics reported with levels of significance and/or confidence intervals? |
Yes
|
| |
8.4.
|
Was "intent to treat" analysis of outcomes done (and as appropriate, was there an analysis of outcomes for those maximally exposed or a dose-response analysis)? |
N/A
|
| |
8.5.
|
Were adequate adjustments made for effects of confounding factors that might have affected the outcomes (e.g., multivariate analyses)? |
Yes
|
| |
8.6.
|
Was clinical significance as well as statistical significance reported? |
Yes
|
| |
8.7.
|
If negative findings, was a power calculation reported to address type 2 error? |
Yes
|
| 9. |
Are conclusions supported by results with biases and limitations taken into consideration? |
Yes
|
| |
9.1.
|
Is there a discussion of findings? |
Yes
|
| |
9.2.
|
Are biases and study limitations identified and discussed? |
Yes
|
| 10. |
Is bias due to study’s funding or sponsorship unlikely? |
Yes
|
| |
10.1.
|
Were sources of funding and investigators’ affiliations described? |
Yes
|
| |
10.2.
|
Was the study free from apparent conflict of interest? |
Yes
|
| |
| |
Copyright American Dietetic Association (ADA).